baber/WOPTO huggingface dataset:
Patent JP-5358057-B2 (JP)
IPC: H05G1/44
Filed: 2006-11-28
Granted: 2013-12-04
Abstract: Before a radiation image is captured, a rate of change of an output signal from an integrator, during a given period of time after the integrator has been reset and until a radiation start signal is supplied, is calculated. An offset voltage signal at a desired time is calculated using the rate of change, and is supplied to a voltage correcting circuit. An output signal from the integrator after a radiation X has started being applied to a subject is corrected based on the calculated offset voltage signal. The corrected output signal from the integrator is supplied to an X-ray tube controller for controlling application of the radiation X to the subject.
Patent JP-4917416-B2 (JP)
IPC: B60N2/90
Filed: 2006-11-29
Granted: 2012-04-18
Abstract: An electric operating device (6) includes an operation member (10) for operating to activate a plurality of electric functions provided at a vehicle seat (1). An operating structure for switching a pivoting position of the operation member (10) is configured as a switching structure for selecting the electric function that is an operational object. Further, an operating structure for switching a slide position in a diametrical direction of the operation member (10) is configured as an operation control structure by which the electric function selected as the operational object is operated to activate. Further, a pushing operation structure of the operation portion (10) is configured as a switching structure for switching a category of an electric function group. The pushing operating structure of the operation member (10) is provided with a return mechanism for returning the operation member (10) operated to be pushed to an initial position taken before the pushing operation by urging the operation member (10).
Patent JP-4930771-B2 (JP)
IPC: F16H25/22
Filed: 2006-12-19
Granted: 2012-05-16
Abstract: <P>PROBLEM TO BE SOLVED: To attain enhancement of durability of a ball screw fitting part and prevention of generation of noise in an electric power steering device.  <P>SOLUTION: Output rotation of an electric motor 6 is transmitted to a first end 17a of a ball nut through a speed-reduction mechanism 7, a rotation member 22 and an elastic coupling 23, and is converted to movement in an axial direction X1 of a rack shaft 5. A first bearing 26 rotatably supports the rotation member 22. The elastic coupling 23 cancels a combination error (misalignment in position and angle) of the ball nut 17 and the rotation member 22. A second bearing 30 supports a second end 17b of the ball nut 17 in an axial direction and allows radial movement of the second end 17b.  <P>COPYRIGHT: (C)2008,JPO&INPIT
Patent JP-4795933-B2 (JP)
IPC: A61F13/00
Filed: 2004-02-09
Granted: 2011-10-19
Abstract: A wound dressing comprising an absorbent pad, an adhesive layer, and a backing layer is described, along with a dressing support layer configured to retain and deliver the wound dressing to a wound, the dressing support layer having a radial configuration that forms a plurality of alternating covered and uncovered portions of the backing layer along the perimeter of the wound dressing.
Patent JP-4339888-B2 (JP)
IPC: H05K7/12
Filed: 2004-03-01
Granted: 2009-10-07
Abstract: The system has an annular spacer (5) associated to a support component (2) on a side directed towards an electric conductor (1). A nut (3) placed at side of a support opposite to the spacer is connected to the spacer by floating fastening units (3a, 3b). The fastening units extend across an oblong hole (6) of the support and blocks rotation of the nut on the support, where the hole allows engagement of a screw (4) in the nut.
Patent JP-4647598-B2 (JP)
IPC: B60T13/57
Filed: 2004-06-22
Granted: 2011-03-09
Abstract: A pneumatic brake booster with short actuating travel, comprising a skirt and a pneumatic piston that are rigidly connected and slideably mounted in a sealed casing to delimit a low-pressure chamber and a variable-pressure chamber and a three-way valve arrangement that is controlled by a control rod connected at a first end to a brake pedal. The three-way valve arrangement having first and second valve seats and a valve that is applied to at least one of the first and second valve seats by a valve spring. The second valve seat being borne by a first longitudinal end of a plunger distributor while the first valve seat is borne by a first longitudinal end of a bushing slideably mounted in a sealed manner in the pneumatic piston over a defined first travel and beyond the defined travel the bushing is secured axially to the pneumatic piston.
Patent JP-4469373-B2 (JP)
IPC: F16K15/18
Filed: 2004-11-27
Granted: 2010-05-26
Abstract: The present invention relates to a flow path control valve capable of preventing a back flow of a fluid by maintaining inner pressure of a valve chamber constant. An object of the present invention is to provide a flow path control valve, which can rapidly and accurately control a flow path for a working fluid and also prevent a back flow of a working fluid without an additional check valve, thereby reducing the size of the product. A flow path control valve of the present invention for achieving the object comprises a housing formed with a valve chamber that can be in fluid communication with an inlet and an outlet; an opening/closing member installed movably within the valve chamber for moving between an opening position and a closing position to open or close a passage between the inlet and the outlet; an elastic member installed within the valve chamber to bias the opening/closing member toward the closing position; and a solenoid installed at a side of the housing to electromagnetically moving the opening/closing valve. A side of the opening/closing member is formed with a pressure equilibrium hole for causing the valve chamber to be in fluid communication with the inlet. A bypass tube is provided to discharge a fluid, which has been introduced into the valve chamber through the pressure equilibrium hole, to the outlet.
Patent JP-4750716-B2 (JP)
IPC: A61K38/16
Filed: 2004-12-02
Granted: 2011-08-17
Abstract: The use and screening of modulators of apoptosis is disclosed. The modulators may be, for example, modulator of NF-κB activity. The modulators may be used, for example, in the treatment of NF-κB-mediated diseases, conditions, and injuries.
Patent JP-4271238-B2 (JP)
IPC: C09K11/06
Filed: 2004-12-08
Granted: 2009-06-03
Abstract: The present invention relates to the use of platinum(II) complexes of the formulae I, II and III as emitter molecules in organic light-emitting diodes (OLEDs), where the radicals are defined in the claims and in the description. Furthermore, the present invention relates to the use of the platinum(II) complexes as light-emitting layer in OLEDs, a light-emitting layer comprising at least one platinum(II) complex, an OLED comprising this light-emitting layer and devices comprising an OLED according to the invention.
Patent JP-4555308-B2 (JP)
IPC: H04N7/16
Filed: 2004-12-17
Granted: 2010-09-29
Abstract: A method and system for a predicting and streaming content utilizing multiple stream capacity. The method includes receiving a selection to change to a different channel, streaming data associated with the different channel from a source to a buffer at a destination, predicting a next channel selection based on the different channel, and streaming data associated with the predicted next channel selection from the source to another buffer at the destination.
Patent JP-5280634-B2 (JP)
IPC: A61P3/10
Filed: 2005-02-04
Granted: 2013-09-04
Abstract: Compounds of formula (I) for clinical treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection and malignant neoplasia. A pharmaceutical composition comprising a compound of formula (I) in an amount giving a daily dosage of from 0.005 mg/kg to 10 mg/kg body weight, in particular from 0.025 mg/kg to 2 mg/kg body weight.
Patent JP-4924118-B2 (JP)
IPC: G02F1/1335
Filed: 2007-03-12
Granted: 2012-04-25
Abstract: <P>PROBLEM TO BE SOLVED: To provide a color filter re-correction method which re-corrects a secondary defect part where a coating film generated by correction work is too high, when correcting a color filter by providing a laser cut frame (correction hole) C1 in a defect part of the color filter and bringing an applying needle having correction ink stuck thereto, into contact with a glass substrate surface within the laser cut frame.  <P>SOLUTION: A second laser cut fame (pinhole) C2 having an area of ≤(15 μm×15 μm) is provided in the secondary defect part wherein the height of the coating film exceeds a standard value, which is 2.4 μm.  <P>COPYRIGHT: (C)2008,JPO&INPIT
Patent JP-4277918-B2 (JP)
IPC: G06F13/00
Filed: 2007-04-13
Granted: 2009-06-10
Abstract: A range search of data is implemented, being a data search method to achieve a constant degree and a logarithmic hop count. A data search device that is located on a network and searches for data shared with another device, includes a dividing unit that divides a logical identifier range based on a logical identifier between own logical identifier and a logical identifier of a successor if a division condition of the logical identifier range requested to search for is met; and a search request transferring unit that transfers a search request including the logical identifier range acquired by the dividing means to a same or different device that meets a forwarding destination condition of the search request.
Patent JP-4422170-B2 (JP)
IPC: H04L29/08
Filed: 2007-05-02
Granted: 2010-02-24
Abstract: A method of handling a variable of a Radio Link Control reset procedure during receiver-side-only re-establishment in a wireless communications system includes resetting a reset state variable, used for counting the number of times a RESET protocol data unit is scheduled to be transmitted, during receiver-side-only re-establishment.
Patent JP-5315632-B2 (JP)
IPC: A01N43/56
Filed: 2007-06-25
Granted: 2013-10-16
Abstract: <P>PROBLEM TO BE SOLVED: To provide a biologically active substance-containing coated granular material coated with a resin that has decomposability in soil and is provided with appropriate elution controllability of the biologically active substance.  <P>SOLUTION: The coated granular material is obtained by coating a biologically active substance-containing granular material with a urethane resin which is obtained by reacting an aromatic polydisocyanate, a polyester polyol having in the molecule an oxy-carbonyl [-O-C(=O)-] partial structure at a rate of at least 15% (in terms of weight), and a polyol containing 2-8C polymethylene glycol.  <P>COPYRIGHT: (C)2008,JPO&INPIT
Patent JP-5270874-B2 (JP)
IPC: A63F5/04
Filed: 2007-08-01
Granted: 2013-08-21
Abstract: <P>PROBLEM TO BE SOLVED: To allow an employee of a game parlor to easily recognize occurrence of an error in an individual game machine without preventing the game parlor from showing off the attractiveness of a specific game machine among a plurality of game machines set in the game parlor.  <P>SOLUTION: A presentation sound such as an in-bonus melody and an alarm sound such as an error sound suggesting occurrence of an error are output from speakers of the slot machine. A sound processing part mounted on a presentation control board reproduces the presentation sound and alarm sound to be output from the speakers. The volume level of the output sounds is set by an electronic volume included in the sound processing part. The sound processing part sets the level of the electronic volume at the level set by a volume control lever when the presentation sound is reproduced and output, but sets the level of the electronic volume at the maximum level regardless of the level set by the volume control lever when the error sound is reproduced and output.  <P>COPYRIGHT: (C)2009,JPO&INPIT
Patent JP-4755633-B2 (JP)
IPC: A23K10/37
Filed: 2007-08-20
Granted: 2011-08-24
Abstract: PCT No. PCT/DK96/00168 Sec. 371 Date Sep. 29, 1997 Sec. 102(e) Date Sep. 29, 1997 PCT Filed Apr. 3, 1996 PCT Pub. No. WO96/31239 PCT Pub. Date Oct. 10, 1996Agent for treatment and prevention of diarrhoea and gastric ulcers in animals and humans, consisting of a mixture of a pectinaceous plant fibre material with a phospholipid, said agent being obtained by adding to the plant fibre material prior to the admixture of phospholipid under intensive stirring a physiologically acceptable liquid organic substance having a surface tension which is significantly lower than that of water, and method of preparing said agent comprising mixing under intensive stirring the finely-milled, dried pectinaceous plant fibre material with 2 to 10% by weight of an organic substance based on the plant fibre material, preferably at least one alcohol, and subsequently adding under stirring from 5 to 15% by weight of lecithin based on the plant fibre material and heated to a temperature of more than 45 DEG  C. to obtain a homogeneous mixture.
Patent JP-5324072-B2 (JP)
IPC: A63F5/04
Filed: 2007-09-26
Granted: 2013-10-23
Abstract: <P>PROBLEM TO BE SOLVED: To provide a game machine capable of normally inspecting the detection conditions of the operation of an operation means for a performance.  <P>SOLUTION: In the case of receiving an inspection command for specifying the operation check of a touch panel and checking the operation of the touch panel, a CPU 91a inhibits command reception interruption processing until a touch operation is detected and does not receive a new command during this time.  <P>COPYRIGHT: (C)2009,JPO&INPIT
Patent JP-4640407-B2 (JP)
IPC: G10L25/06
Filed: 2007-12-07
Granted: 2011-03-02
Abstract: There is provided a signal processing device for processing an audio signal, the signal processing device including: an onset time detection unit for detecting an onset time based on a level of the audio signal; and a beat length calculation unit for obtaining a beat length Q by: setting an objective function P(Q|X) and an auxiliary function, the objective function P(Q|X) representing a probability that, when an interval X between the onset times is given, the interval X is the beat length Q, the auxiliary function being for inducing an update of both the beat length Q and a tempo Z that results in a monotonous increase of the objective function P(Q|X); and repeating maximization of the auxiliary function to have the auxiliary function converge.
Patent JP-5263706-B2 (JP)
IPC: E03D9/08
Filed: 2007-12-28
Granted: 2013-08-14
Abstract: <P>PROBLEM TO BE SOLVED: To provide a private part washing device capable of stopping private part washing operation without fail during the private part washing operation.  <P>SOLUTION: This private part washing device is provided with a function part for performing the private part washing operation and an operation part having a stop switch for stopping the private part washing operation by the function part. The operation part can switch between an inputting possible state for giving instructions for stopping the private part washing operation by operating the stop switch and an inputting impossible state for making it impossible to give instructions for stopping the private part washing operation by operating the stop switch. The private part washing operation is stopped to switch from the inputting possible state into the inputting impossible state.  <P>COPYRIGHT: (C)2009,JPO&INPIT
Patent JP-4603037-B2 (JP)
IPC: H04S3/02
Filed: 2005-04-12
Granted: 2010-12-22
Abstract: A method and apparatus for reconstructing N audio channels from M audio channels is disclosed. The method includes receiving a bitstream containing an encoded audio signal representing the M audio channels and decoding the encoded audio signal to obtain a frequency domain representation of the M audio channels. The method further includes extracting a parameter from the bitstream and reconstructing at least one of the N audio channels using the parameter. The parameter represents an angle between two signals, at least one of which is included in the M audio channels.
Patent JP-4842266-B2 (JP)
IPC: A61F9/00
Filed: 2005-07-20
Granted: 2011-12-21
Abstract: A kit for determining a hypothetical cornea for use with post-LASIK and post myopia Ortho-K amendment. The kit has a reference table for determining conformation data by using at least one of following data: pre-treatment KM readings, post-treatment KM readings, power reduced from before- to after-treatment, and post-treatment cornea optical zone. The kit further comprises a plurality of conformed lenses based on the conformation data in predetermined increments from the reference table. The pre-treatment KM readings comprise pre-operative or pre-ortho-K readings. The post-treatment KM readings comprise post-operative or post ortho-K readings. The post-treatment cornea optical zone comprises post-operative or post-ortho-K cornea optical zone. Also, a method of determining a hypothetical cornea for use with post-LASIK and post myopia Ortho-K amendment is disclosed. The method has inputting pre-treatment KM readings, inputting post-treatment KM readings, inputting power reduced from before- to after treatment, inputting post-treatment cornea optical zone, calculating conformation data, which is adapted to be used to generate specification for conformed lenses. Another kit for determining a hypothetical cornea for use with Keratoconus and post-hyperopia Ortho-K amendment can be constructed using at least one of following data: pre-altered KM readings, post-altered KM readings, pre-altered refraction error, and post altered specifications. The kit further comprises a plurality of conformed lenses based on the conformation data in predetermined increments from the reference table. The pre-altered KM readings comprise pre-keratoconus or pre-hyperopia ortho-K readings. The pre-altered refraction errors comprise refraction errors from a set of normal corneas. The post-altered specifications comprise cone widths of Keratoconus or steepened cornea zone of hyperopic Ortho-K and also magnitude of off centering of the cone apex.
Patent JP-5103181-B2 (JP)
IPC: A61B8/00
Filed: 2005-08-15
Granted: 2012-12-19
Abstract: An ultrasound transducer (40,70,100) comprises a combined individual die integrated circuit (42,72,102) and an array of acoustic elements (44,74,104) coupled to the combined individual die integrated circuit via an array of flip-chip bumps (46,76,106). The combined individual die integrated circuit includes a first integrated circuit die (48,78,108) aligned with at least one additional integrated circuit die (50,80,(110,112)). In addition, the first integrated circuit die, the at least one additional die integrated circuits, and the array of acoustic elements together form a large aperture transducer array.
Patent JP-4480041-B2 (JP)
IPC: A61B6/14
Filed: 2005-10-07
Granted: 2010-06-16
Abstract: The apparatus (100,200,300,400) includes, an X-ray light source part (110,210,320,410), an X-ray sensor part (120,220,320,420) having a panoramic sensor (221,321,421) and/or a CT sensor (223,323,423) for detecting X-rays which are generated from the X-ray light source part and pass through an object, a rotary arm (140,240,340,440) for arranging the X-ray light source part and the X-ray sensor part thereon in such a way as to be opposed to each other, a rotary arm supporting member (150), and rotary arm driving means (160), wherein a distance between the X-ray light source part and the X-ray sensor part arranged opposed to each other with respect to the rotary arm is variable. The apparatus can conduct all of panoramic photographing and CT photographing, and provide the optimum enlargement ratio according to whether the panoramic photographing or the CT photographing is conducted.
Patent JP-5123663-B2 (JP)
IPC: A61K35/19
Filed: 2005-10-17
Granted: 2013-01-23
Abstract: The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis.
Patent JP-4886700-B2 (JP)
IPC: A61K31/495
Filed: 2005-12-21
Granted: 2012-02-29
Abstract: The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. In addition, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having Formula (I): or a pharmaceutically acceptable salt, solvate or hydrate thereof. The compositions are useful in pharmaceutical compositions whose use includes the treatment of obesity.
Patent JP-5293922-B2 (JP)
IPC: A63F7/02
Filed: 2008-01-07
Granted: 2013-09-18
Abstract: <P>PROBLEM TO BE SOLVED: To provide a game machine that can effectively improve the appearance of a shielding member in an open condition.  <P>SOLUTION: A game machine is provided with a variable part (screen of a decoration design display unit 42) that changes modes based on a predetermined momentum, shielding members 441 and 442 that cover at least one part of the variable part, and drive means, i.e. shutter drive mechanisms 445R and 445L, that drive to open/close the shielding members 441 and 442. The machine is further provided with decorating effect parts 441D and 442D formed in the shielding members 441 and 442 to change the direction as the shielding members 441 and 442 open and to face more toward the front of the game machine when the shielding members 441 and 442 are open than when they are closed.  <P>COPYRIGHT: (C)2009,JPO&INPIT
Patent JP-4767265-B2 (JP)
IPC: H01L29/74
Filed: 2008-01-15
Granted: 2011-09-07
Abstract: <P>PROBLEM TO BE SOLVED: To reduce element resistance in on-operation without decreasing a breakdown voltage in off operation.  <P>SOLUTION: An n<SP>-</SP>layer 2 is formed on the main surface of a p-type semiconductor substrate 1. A p<SP>-</SP>diffusion region 5 is formed on the surface of the n<SP>-</SP>layer 2. A p diffusion region 6 is formed so as to merge one end of the p<SP>-</SP>diffusion region 5. Within the p<SP>-</SP>diffusion region 5, a plurality of p diffusion regions 20 containing p-type impurities are formed, which have high concentration as compared with the p<SP>-</SP>diffusion region 5. A p diffusion region 3 is formed spaced apart from the p<SP>-</SP>diffusion region 5. A gate electrode 9 is formed on the surface of the n<SP>-</SP>layer 2 positioned between the p diffusion region 3 and the p<SP>-</SP>diffusion region 5 through an oxide film 10. A drain electrode 12 is formed in contact with the surface of the p diffusion region 6. Additionally, an n diffusion region 4 is formed adjacent to the p diffusion region 3, and a source electrode 11 is formed in contact with both the surfaces of the n diffusion region 4 and the p diffusion region 3.  <P>COPYRIGHT: (C)2008,JPO&INPIT
Patent JP-4362535-B2 (JP)
IPC: A61K31/55
Filed: 2008-01-15
Granted: 2009-11-11
Abstract: The present invention provides a cyclic amide derivative useful as a drug for treating thrombosis, which is represented by the formula (I):   
wherein R 1  represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent chain hydrocarbon group, a represents 0, 1, or 2, X 1  represents an optionally substituted lower alkylene or an optionally substituted lower alkenylene, Y 1  represents - C(O)-, -S(O)- or -S(O) 2 -, A represents a piperazine ring which may be further substituted or a piperidine ring which may be further substituted, X 2  represents a bond or an optionally substituted lower alkylene, Y 2  represents -C(O)-, -S(O)-, -S(O) 2 - or -C(=NR 7 )-, X 3  represents an optionally substituted C 1-4  alkylene or an optionally substituted C 2-4  alkenylene, Z 3  represents -N(R 4 )-, -O- or a bond, Z 1  represents -C(R 2 )(R 2' )-, -N(R 2 )-, etc., and Z 2  represents - C(R 3 )(R 3' )-, -N(R 3 )-, etc., or a salt thereof.